相关实验视频

Updated: Jan 16, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

工程 scFv免疫疗法:从CAR T细胞到双特异性抗体

Mohammad Chand Jamali¹, Amged Gaffer Mostafa Gaffer¹, Hakeem Ghani Hassan²

¹College of Medical and Health Sciences, Liwa University, Al Ain, Abu Dhabi, United Arab Emirates.

International immunopharmacology

|September 30, 2025

概括

单链可变片段 (scFvs) 正在通过实现精确瘤向来彻底改变癌症免疫疗法. 这些抗体碎片增强了CAR T细胞和双特异性参与者等疗法,改变了精确瘤学.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

单链可变片段 (scFvs) 是对癌症免疫治疗至关重要的工程抗体片段.
它们的模块化,特异性和具有成本效益的生产有助于有针对性的抗原识别.

研究的目的:

审查scFvs在各种癌症免疫疗法模式中的不断扩大的治疗应用.
突出scFv优化方面的进展,并解决临床翻译方面的挑战.

主要方法:

对基于scFv的癌症疗法进行的临床前和临床研究的文献综述.
分析scFv在CAR T细胞疗法,双特异性参与者,检查点封锁和药物输送系统中的作用.

主要成果:

scFv对于CAR T细胞的有效性,双特异性T细胞参与剂和向性药物递送至关重要.
在血液恶性瘤中观察到临床成功,在固体瘤中持续存在挑战.
半衰期延长,稳定性和组合策略的进展正在改善scFv的性能.

结论:

基于scFv的疗法正在通过向性免疫调节改变精密瘤学.
持续优化scFvs对于克服限制和增强抗瘤免疫力至关重要.

关键词:

抗体工程是一种抗体工程.它们是BITE,它们是BITE.在CAR-T细胞疗法中.免疫检查站封锁免疫检查站封锁瘤免疫疗法免疫疗法 scFvv 在线阅读

更多相关视频

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...